Hemogenyx Pharmaceuticals Plc (HOPHF)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
-1.2000 (-96.77%)
Jun 12, 2025, 8:00 PM EDT
Hemogenyx Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
10.75M USD
Revenue Chart
* This company reports financials in GBP.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Hemogenyx Pharmaceuticals News
- 2 days ago - Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion - Accesswire
- 15 days ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 16 days ago - Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests - Accesswire
- 5 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol - Accesswire
- 6 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing - Accesswire
- 6 weeks ago - Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy - Accesswire
- 7 weeks ago - Hemogenyx Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report - Accesswire